PA

Pinkal Amarsibhai Shekhaliya

Active Director Director DIN 05179704
DIN 05179704 First appointment Jan 2012 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jan 2012
Shareholding value •••• Premium profile

About Pinkal Amarsibhai Shekhaliya

Data last updated:

Pinkal Amarsibhai Shekhaliya is a Director at Bookmyparts Networks Private Limited (since 2015), Additional Director at Kp Tech Machine (India) Private Limited (since 2012) and Director at Center For Bio Meditech Confederation (since 2020). The companies operate in Trading, Machinery and Equipment and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹15.10 Cr; the largest is Bookmyparts Networks Private Limited at ₹8.81 Cr (FY 2025). Earlier, Pinkal Amarsibhai Shekhaliya was a Director at Deltora Biopolymers Private Limited (2022–2025).

DIN 05179704
Primary Designation Director
Industry Trading
First Appointment 21 Jan 2012
Oldest Company Age 15 yrs
Largest company Bookmyparts Networks Private Limited · ₹8.81 Cr (FY 2025)
Combined revenue ₹15.10 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bookmyparts Networks Private Limited U52190GJ2015PTC084690
Director07 Oct 20152015₹8.81 Cr (FY 2025)Active
Additional Director21 Jan 20122011₹6.29 Cr (FY 2024)Active
Director18 Jun 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Deltora Biopolymers Private Limited U25200GJ2022PTC134339
Director29 Jul 20222022₹5.52 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kp Tech Machine (India) Private Limited
Bookmyparts Networks Private Limited
Center For Bio Meditech Confederation
Deltora Biopolymers Private Limited
Premium access

Shareholding and investment profile for Pinkal Amarsibhai Shekhaliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pinkal Amarsibhai Shekhaliya

Pinkal Amarsibhai Shekhaliya currently holds 3 directorships: Bookmyparts Networks Private Limited (Director, since 07 Oct 2015, revenue ₹8.81 Cr (FY 2025)); Kp Tech Machine (India) Private Limited (Additional Director, since 21 Jan 2012, revenue ₹6.29 Cr (FY 2024)); Center For Bio Meditech Confederation (Director, since 18 Jun 2020).

Pinkal Amarsibhai Shekhaliya was first appointed on 21 Jan 2012 as Additional Director at Kp Tech Machine (India) Private Limited. The most recent appointment on record is 29 Jul 2022 at Deltora Biopolymers Private Limited.

The 2 current companies of Pinkal Amarsibhai Shekhaliya that report revenue have a combined latest revenue of ₹15.10 Cr: Bookmyparts Networks Private Limited ₹8.81 Cr (FY 2025); Kp Tech Machine (India) Private Limited ₹6.29 Cr (FY 2024).

Pinkal Amarsibhai Shekhaliya held 1 earlier board appointment: Deltora Biopolymers Private Limited (Director, 29 Jul 2022 to 31 Mar 2025).

The current boards of Pinkal Amarsibhai Shekhaliya's companies include Bhartiben Pinkalkumar Shekhaliya (Bookmyparts Networks Private Limited), Bhupeshkumar Nathalal Patel (Bookmyparts Networks Private Limited), Pareshbhai Bhagwanbhai Vaghasiya (Bookmyparts Networks Private Limited), Piyushkumar Dhirubhai Gajera (Bookmyparts Networks Private Limited), Prit Bhupesh Patel (Bookmyparts Networks Private Limited), Amarsibhai Mohanbhai Patel (Kp Tech Machine (India) Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available